Replies to post #7558 on GTC Biotherapeutics (fka GTCB)

[jessellivermore]

The logical assumption is the good P3 TLD greatly ups the odds of GTCB getting a partnership(s). All Biotechs can be divided into two groups....Those with a sustainable revenue stream and those without. If GTCB manages that, then in the immortal words from the movie Wall Street,, This baby's going to Pluto

[croumagnon]

"much of the risk has been taken out of the equation...
hoping for a bigger day tomorrow than most anticipate."

I agree with your assessment and, although I already have a sizable holding in GTCB (currently my largest biotech holding) I just added another 25,000 shares after hours and I was willing (and did) to go as high as $1.25 to finish filling those.

Once this story gets out, I expect GTCB to spike to $1.8 if not more because, as you say, the risk is now out of the equation which in this treacherous market is huge. It may not happen tomorrow on account of the election super-tuesday that will oversahdow any GTCB news but I am expecting to see $1.8 before the end of the week...

"a strong partnership and $2.50 - $3 soon thereafter."

Based on their timeline for a partnershiop announcement this quarter, I expect we shall see those numbers sooner than most expect...